Share on StockTwits

Johnson & Johnson (NYSE:JNJ) is set to release its Q214 earnings data on Tuesday, July 15th. Analysts expect Johnson & Johnson to post earnings of $1.54 per share and revenue of $18.86 billion for the quarter.

Shares of Johnson & Johnson (NYSE:JNJ) opened at 105.10 on Monday. Johnson & Johnson has a 52 week low of $85.50 and a 52 week high of $106.74. The stock’s 50-day moving average is $103.7 and its 200-day moving average is $97.30. The company has a market cap of $297.3 billion and a price-to-earnings ratio of 20.24.

A number of research firms have recently commented on JNJ. Analysts at Barclays reiterated an “equal weight” rating on shares of Johnson & Johnson in a research note on Wednesday, July 2nd. They now have a $102.00 price target on the stock, up previously from $99.00. On a related note, analysts at JPMorgan Chase & Co. reiterated a “neutral” rating on shares of Johnson & Johnson in a research note on Monday, June 30th. They now have a $108.00 price target on the stock, up previously from $100.00. Finally, analysts at Deutsche Bank raised their price target on shares of Johnson & Johnson from $52.00 to $53.00 in a research note on Tuesday, May 20th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and six have issued a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus target price of $92.71.

Johnson & Johnson is a holding company. The Company is engaged in the research and development, manufacture and sale of a broad range of products in the health care field.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.